Interim clinical considerations for use of COVID-19 vaccines in the United States

i

Interim clinical considerations for use of COVID-19 vaccines in the United States

Supporting Files Public Domain

November 3, 2023
By National Center for Immunization and Respiratory Diseases (U.S.)

File Language:

English

Details

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.)
Description:

Healthcare providers who administer the Moderna COVID-19 Vaccine (2023-2024 Formula) to individuals ages 6 months through 11 years should ensure the correct volume of the vaccine (0.25 mL) is withdrawn from the vial and administered to the recipient. Discard vial and excess volume after extracting a single dose.

Summary of recent changes (last updated November 3, 2023):

Guidance added to COVID-19 vaccination schedules for correct dosage and administration of updated (2023–2024 Formula) Moderna COVID-19 Vaccine in children ages 6 months–11 years.
Subjects:

Coronavirus Infections/prevention & Control COVID-19 Vaccines COVID-19/prevention & Control Vaccination Vaccination Coverage
Document Type:

Webpage
Place as Subject:

United States
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:4a8282882129de1685a82020c1f857a9c1f4d14a674b4bba73411b901be7c53b
Download URL:

https://stacks.cdc.gov/view/cdc/135933/cdc_135933_DS1.pdf
File Type:

[PDF - 330.22 KB ]

interim-considerations-us.html

html

File Language:

English

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.